🔎 Trials Near Me

Beranda › Glioma › Ohio › Cincinnati

Uji klinis Glioma di Cincinnati, OH

9 studi untuk Glioma mencari peserta di lokasi sekitar Cincinnati (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)

Menerima pesertaFase 1/2
  • Cincinnati Children's Hospital Medical Center, Cincinnati
12 Months – 21 Years · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT05099003

ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas

Menerima pesertaFase 2
  • Cincinnati Children's Hospital, Cincinnati
12 Months – 39 Years · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT06838676

Targeted Pediatric High-Grade Glioma Therapy

Menerima pesertaStudi observasional
  • Cincinnati Children's Hospital Medical Center, Cincinnati
12 Months – 39 Years · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT05839379

Study of Olutasidenib and Temozolomide in HGG

Menerima pesertaFase 2
  • Cincinnati Children's Hospital Medical Center, Cincinnati
Usia 12 hingga 39 · Semua jenis kelamin · Diperbarui 1 Sep 2026 · NCT06161974

PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma

Menerima pesertaFase 2
  • Cincinnati Children's Hospital Medical Center, Cincinnati
Usia 3 hingga 39 · Semua jenis kelamin · Diperbarui 24 Agu 2026 · NCT05096481

Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors

Menerima pesertaFase 1/2
  • Cincinnati Children's Hospital Medical Center, Cincinnati
Usia 4 hingga 39 · Semua jenis kelamin · Diperbarui 20 Jul 2026 · NCT05278208

Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion

Menerima pesertaFase awal 1Sukarelawan sehat diterima
  • Cincinnati Children's Hospital Medical Center, Cincinnati
Usia 1 hingga 21 · Semua jenis kelamin · Diperbarui 29 Jun 2026 · NCT06333899

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

Menerima pesertaFase 2
  • Cincinnati Children's Hospital Medical Center, Cincinnati
12 Months – 39 Years · Semua jenis kelamin · Diperbarui 29 Mei 2026 · NCT05843253

A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion

Menerima pesertaFase awal 1
  • Cincinnati Children's Hospital Medical Center, Cincinnati
Hingga usia 21 · Semua jenis kelamin · Diperbarui 18 Mar 2026 · NCT04655404

Uji klinis Glioma di kota lain

Studi lain di Cincinnati

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.